Source Citation

Appleton S, Poole P, Smith B, et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006(3):CD001104. https://pubmed.ncbi.nlm.nih.gov/16855959

Clinical Impact Ratings

GIM/FP/GP: 5 out of 7

Pulmonology: 6 out of 7

References

  • 1 Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26. [PMID: 16424409] Google Scholar
  • 2 Vestbo J. The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J. 2004;24:206-10. [PMID: 15332386] Google Scholar
  • 3 Barr RG, Bourbeau J, Camargo CA, et al. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax. 2006;61:854-62. [PMID: 16844726] Google Scholar

IMPORTANT: This site is undergoing maintenance for the next 24 hours, starting 3/29/21 at 7:00 PM EDT. Individual users will not be able to log into their accounts to comment
on articles or take CME. Institutional administrators will not be able to make changes. Contact [email protected] with questions.